Victory Capital Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.26M | Buy |
38,114
+16,538
| +77% | +$546K | ﹤0.01% | 1742 |
|
|
2025
Q1 | $867K | Sell |
21,576
-140
| -0.6% | -$5.63K | ﹤0.01% | 1868 |
|
|
2024
Q4 | $1.02M | Sell |
21,716
-13,888
| -39% | -$653K | ﹤0.01% | 1801 |
|
|
2024
Q3 | $1.88M | Sell |
35,604
-1,435
| -4% | -$75.8K | ﹤0.01% | 1501 |
|
|
2024
Q2 | $2.01M | Buy |
37,039
+3,436
| +10% | +$186K | ﹤0.01% | 1442 |
|
|
2024
Q1 | $2.36M | Sell |
33,603
-158,051
| -82% | -$11.1M | ﹤0.01% | 1410 |
|
|
2023
Q4 | $16M | Buy |
191,654
+174,848
| +1,040% | +$14.6M | 0.02% | 863 |
|
|
2023
Q3 | $495K | Buy |
16,806
+1,091
| +7% | +$32.1K | ﹤0.01% | 1994 |
|
|
2023
Q2 | $513K | Buy |
15,715
+320
| +2% | +$10.4K | ﹤0.01% | 1972 |
|
|
2023
Q1 | $542K | Sell |
15,395
-70,037
| -82% | -$2.46M | ﹤0.01% | 1973 |
|
|
2022
Q4 | $3.91M | Sell |
85,432
-513,796
| -86% | -$23.5M | ﹤0.01% | 1255 |
|
|
2022
Q3 | $29M | Buy |
599,228
+523,279
| +689% | +$25.4M | 0.03% | 655 |
|
|
2022
Q2 | $2.98M | Buy |
75,949
+52,886
| +229% | +$2.08M | ﹤0.01% | 1361 |
|
|
2022
Q1 | $920K | Buy |
23,063
+14,398
| +166% | +$574K | ﹤0.01% | 1850 |
|
|
2021
Q4 | $395K | Sell |
8,665
-1,106
| -11% | -$50.4K | ﹤0.01% | 2281 |
|
|
2021
Q3 | $349K | Buy |
+9,771
| New | +$349K | ﹤0.01% | 2332 |
|
|
2021
Q2 | – | Sell |
-9,933
| Closed | -$231K | – | 2766 |
|
|
2021
Q1 | $231K | Buy |
+9,933
| New | +$231K | ﹤0.01% | 2486 |
|
|
2020
Q2 | – | Sell |
-16,170
| Closed | -$190K | – | 2706 |
|
|
2020
Q1 | $190K | Buy |
16,170
+4,799
| +42% | +$56.4K | ﹤0.01% | 2340 |
|
|
2019
Q4 | $121K | Buy |
11,371
+3,057
| +37% | +$32.5K | ﹤0.01% | 2480 |
|
|
2019
Q3 | $95K | Buy |
+8,314
| New | +$95K | ﹤0.01% | 2454 |
|